Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves hair loss in women with hyperandrogenism.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Iron deficiency common in women, not always linked to hair loss; more research needed.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Certain hormone treatments can improve acne and related conditions in women.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

The document concludes that more research is needed to fully understand the causes of PCOS.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.